Loading organizations...
Loading organizations...
Developer of novel therapies for autoimmune diseases.
Aristea Therapeutics has raised $78.0M across 2 funding rounds.
Aristea Therapeutics has raised $78.0M in total across 2 funding rounds.
Aristea Therapeutics has raised $78.0M in total across 2 funding rounds.
Aristea Therapeutics's investors include Fidelity Management & Research Company, Maurice Mezzino, Novo Holdings, Loretta Tse, Tiba Aynechi.
Aristea Therapeutics has raised $78.0M across 2 funding rounds. Most recently, it raised $63.0M Series B in July 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jul 27, 2021 | $63.0M Series B | Fidelity Management & Research Company | Maurice Mezzino, Novo Holdings, Loretta Tse |
| Dec 18, 2018 | $15.0M Series A | Tiba Aynechi |